Atea Pharmaceuticals, Inc.

NasdaqGS:AVIR Stock Report

Mkt Cap: US$379.0m

Atea Pharmaceuticals Financial Health

How is Atea Pharmaceuticals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: AVIR's short term assets ($681.9M) exceed its short term liabilities ($15.6M).

Long Term Liabilities: AVIR's short term assets ($681.9M) exceed its long term liabilities ($7.8M).


Debt to Equity History and Analysis

Debt Level: AVIR is debt free.

Reducing Debt: AVIR has not had any debt for past 5 years.

Debt Coverage: AVIR has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: AVIR has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies